skip to main content

SciTech ConnectSciTech Connect

Title: 213Bi-DOTATOC receptor-targeted alph-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

Authors:
 [1] ;  [2] ;  [3] ;  [3] ;  [3] ;  [4] ;  [4] ;  [4]
  1. ORNL
  2. Heidelberg University, Germany
  3. University of Heidelberg
  4. European Commission Joint Research Centre
Publication Date:
OSTI Identifier:
1158757
DOE Contract Number:
DE-AC05-00OR22725
Resource Type:
Journal Article
Resource Relation:
Journal Name: European Journal of Nuclear Medicine
Research Org:
Oak Ridge National Laboratory (ORNL)
Sponsoring Org:
USDOE
Country of Publication:
United States
Language:
English